phase readout
saveNCT04438382: Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
TERMINATEDupdated 2mo ago
community read0 votes
Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Steroid-Refractory Pneumonitis
view source ↗
comments(0)
5-min edit window · permanent after that